Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $1.07M in the quarter ending June 30, 2024, a decrease of -96.45%. This brings the company's revenue in the last twelve months to $68.68M, down -58.79% year-over-year. In the year 2023, Repare Therapeutics had annual revenue of $51.13M, down -61.21%.

• Revenue (ttm): $68.68M
• Revenue Growth: -58.79%
• P/S Ratio: 2.31
• Revenue / Employee: $383,704
• Employees: 179
• Market Cap: 159.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	51.13M	-80.70M	-61.21%
Dec 31, 2022	131.83M	124.23M	1,634.61%
Dec 31, 2021	7.60M	7.47M	5,529.63%
Dec 31, 2020	135.00K	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.